WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Denali Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Denali Therapeutics Inc. DNLI |
WELLINGTON MANAGEMENT CO LLP | 10,727,450 7.490% |
3,452,733 (+47.46%) |
Filing |
| 2024-02-08 10:11 am Purchase |
2023-12-29 | 13G | Denali Therapeutics Inc. DNLI |
WELLINGTON MANAGEMENT CO LLP | 7,274,717 5.260% |
7,274,717 (New Position) |
Filing |